Journal Mobile Options
Table of Contents
Vol. 27, No. 3, 2009
Issue release date: September 2009

Risk of Radiation and Choice of Imaging

Herfarth H. · Palmer L.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Radiological imaging plays an important role in the diagnosis and management of patients with inflammatory bowel diseases (IBD). The barium or contrast techniques enteroclysis (SBE) and small bowel follow through (SBFT) are still the mainstays in small bowel imaging. However, abdominal CT and MRI, including enteroclysis, have comparable sensitivity and specificity in detecting intestinal pathologies and have gained in popularity over conventional techniques. The cancer risk associated with diagnostic procedures employing radiation has been receiving increasing attention over the last few years. The cumulative exposure to ionizing radiation may be a specific concern in young patients with IBD, who are more susceptible than adults to the risks of ionizing radiation. Substantial exposure to radiation seems to be mainly caused by CT examinations of the abdomen. For that reason, imaging methods such as MRI or ultrasound should be considered first when debating between alternative imaging strategies, particularly in young IBD patients. The major drawbacks of MRI are its limited availability and greater costs compared to CT. Moreover, the diagnostic accuracy of abdominal ultrasound is clearly operator dependent, which limits the range of its applications. In light of these concerns, diagnostic imaging studies using radiation will continue to play an important role in the evaluation of patients with IBD. Therefore, we need to develop low-radiation imaging protocols or improve access to MRI imaging procedures. We also need to identify subsets of IBD patients who are at greater risk of a significant lifetime exposure to radiation and develop methods to monitor their radiation exposure rate.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Hirche TO, Russler J, Schroder O, Schuessler G, Kappeser P, Caspary WF, Dietrich CF: The value of routinely performed ultrasonography in patients with Crohn disease. Scand J Gastroenterol 2002;37:1178–1183.
  2. Horsthuis K, Bipat S, Bennink RJ, Stoker J: Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008;247:64–79.
  3. Parente F, Greco S, Molteni M, Cucino C, Maconi G, Sampietro GM, Danelli PG, Cristaldi M, Bianco R, Gallus S, Bianchi Porro G: Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther 2003;18:1009–1016.
  4. Parente F, Greco S, Molteni M, Anderloni A, Bianchi Porro G: Imaging inflammatory bowel disease using bowel ultrasound. Eur J Gastroenterol Hepatol 2005;17:283–291.
  5. Parente F, Greco S, Molteni M, Anderloni A, Sampietro GM, Danelli PG, Bianco R, Gallus S, Bianchi Porro G: Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, X-ray studies, and ileocolonoscopy. Gut 2004;53:1652–1657.
  6. Gasche C, Moser G, Turetschek K, Schober E, Moeschl P, Oberhuber G: Transabdominal bowel sonography for the detection of intestinal complications in Crohn’s disease. Gut 1999;44:112–117.
  7. Parente F, Maconi G, Bollani S, Anderloni A, Sampietro G, Cristaldi M, Franceschelli N, Bianco R, Taschieri AM, Bianchi Porro G: Bowel ultrasound in assessment of Crohn’s disease and detection of related small bowel strictures: a prospective comparative study versus X-ray and intraoperative findings. Gut 2002;50:490–495.
  8. Bernstein CN, Boult IF, Greenberg HM, van der Putten W, Duffy G, Grahame GR: A prospective randomized comparison between small bowel enteroclysis and small bowel follow-through in Crohn’s disease. Gastroenterology 1997;113:390–398.
  9. Marshall JK, Cawdron R, Zealley I, Riddell RH, Somers S, Irvine EJ: Prospective comparison of small bowel meal with pneumocolon versus ileo-colonoscopy for the diagnosis of ileal Crohn’s disease. Am J Gastroenterol 2004;99:1321–1329.
  10. Herlinger H: A modified technique for the double-contrast small bowel enema. Gastrointest Radiol 1978;3:201–207.
  11. Herlinger H: The small bowel enema and the diagnosis of Crohn’s disease. Radiol Clin North Am 1982;20:721–742.
  12. Schunk K, Kern A, Oberholzer K, Kalden P, Mayer I, Orth T, Wanitschke R: Hydro-MRI in Crohn’s disease: appraisal of disease activity. Invest Radiol 2000;35:431–437.
  13. Rieber A, Wruk D, Potthast S, Nussle K, Reinshagen M, Adler G, Brambs HJ: Diagnostic imaging in Crohn’s disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 2000;15:176–181.
  14. Madsen SM, Thomsen HS, Munkholm P, Schlichting P, Davidsen B: Magnetic resonance imaging of Crohn disease: early recognition of treatment response and relapse. Abdom Imaging 1997;22:164–166.
  15. Madsen SM, Thomsen HS, Schlichting P, Dorph S, Munkholm P: Evaluation of treatment response in active Crohn’s disease by low-field magnetic resonance imaging. Abdom Imaging 1999;24:232–239.
  16. Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H: Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 2000;215:717–725.
  17. Maccioni F, Viscido A, Marini M, Caprilli R: MRI evaluation of Crohn’s disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents. Abdom Imaging 2002;27:384–393.
  18. Maccioni F, Viscido A, Broglia L, Marrollo M, Masciangelo R, Caprilli R, Rossi P: Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000;25:219–228.
  19. Shoenut JP, Semelka RC, Magro CM, Silverman R, Yaffe CS, Micflikier AB: Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994;19:31–35.
  20. Holzknecht N, Helmberger T, von Ritter C, Gauger J, Faber S, Reiser M: MRI of the small intestine with rapid MRI sequences in Crohn disease after enteroclysis with oral iron particles. Radiologe 1998;38:29–36.
  21. Koh DM, Miao Y, Chinn RJ, Amin Z, Zeegen R, Westaby D, Healy JC: MR imaging evaluation of the activity of Crohn’s disease. AJR Am J Roentgenol 2001;177:1325–1332.
  22. Small WC, DeSimone-Macchi D, Parker JR, et al: A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis. J Magn Reson Imaging 1999;10:15–24.
  23. Kettritz U, Isaacs K, Warshauer DM, Semelka RC: Crohn’s disease. Pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 1995;21:249–253.
  24. Low RN, Sebrechts CP, Politoske DA, Bennett MT, Flores S, Snyder RJ, Pressman JH: Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium-enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 2002;222:652–660.
  25. Low RN, Francis IR, Politoske D, Bennett M: Crohn’s disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging 2000;11:127–135.
  26. Marcos HB, Semelka RC: Evaluation of Crohn’s disease using half-fourier RARE and gadolinium-enhanced SGE sequences: initial results. Magn Reson Imaging 2000;18:263–268.
  27. Frokjaer JB, Larsen E, Steffensen E, Nielsen AH, Drewes AM: Magnetic resonance imaging of the small bowel in Crohn’s disease. Scand J Gastroenterol 2005;40:832–842.
  28. Bernstein CN, Greenberg H, Boult I, Chubey S, Leblanc C, Ryner L: A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn’s disease. Am J Gastroenterol 2005;100:2493–2502.
  29. Aschoff AJ, Zeitler H, Merkle EM, Reinshagen M, Brambs HJ, Rieber A: MR enteroclysis for nuclear spin tomographic diagnosis of inflammatory bowel diseases with contrast enhancement. Rofo 1997;167:387–391.
  30. Rieber A, Wruk D, Nussle K, Aschoff AJ, Reinshagen M, Adler G, Brambs HJ, Tomczak R: MRI of the abdomen combined with enteroclysis in Crohn disease using oral and intravenous Gd-DTPA. Radiologe 1998;38:23–28.
  31. Jamieson DH, Shipman PJ, Israel DM, Jacobson K: Comparison of multidetector CT and barium studies of the small bowel: inflammatory bowel disease in children. AJR Am J Roentgenol 2003;180:1211–1216.
  32. Mako EK, Mester AR, Tarjan Z, Karlinger K, Toth G: Enteroclysis and spiral CT examination in diagnosis and evaluation of small bowel Crohn’s disease. Eur J Radiol 2000;35:168–175.
  33. Fishman EK, Wolf EJ, Jones B, Bayless TM, Siegelman SS: CT evaluation of Crohn’s disease: effect on patient management. AJR Am J Roentgenol 1987;148:537–540.
  34. Herfarth H, Grunert M, Klebl F, Strauch U, Feuerbach S, Scholmerich J, Rogler G, Schreyer AG: Frequency and nature of incidental extra-enteric lesions found on magnetic resonance enterography (MR-E) in patients with inflammatory bowel diseases (IBD). PLoS One 2009;4:e4863.
  35. Booya F, Akram S, Fletcher JG, Huprich JE, Johnson CD, Fidler JL, Barlow JM, Solem CA, Sandborn WJ, Loftus EV Jr: CT enterography and fistulizing Crohn’s disease: clinical benefit and radiographic findings. Abdom Imaging 2009;34:467–475.
  36. Albert JG, Martiny F, Krummenerl A, Stock K, Lesske J, Gobel CM, Lotterer E, Nietsch HH, Behrmann C, Fleig WE: Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut 2005;54:1721–1727.
  37. Solem CA, Loftus EV Jr, Fletcher JG, et al: Small-bowel imaging in Crohn’s disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc 2008;68:255–266.
  38. Triester SL, Leighton JA, Leontiadis GI, Gurudu SR, Fleischer DE, Hara AK, Heigh RI, Shiff AD, Sharma VK: A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-structuring small bowel Crohn’s disease. AJR Am J Gastroenterol 2006;101:954–964.
  39. Martin DR, Semelka RC: Health effects of ionising radiation from diagnostic CT. Lancet 2006;367:1712–1714.
  40. Barcellos-Hoff MH: Cancer as an emergent phenomenon in systems radiation biology. Radiat Environ Biophys 2008;47:33–38.
  41. Brenner DJ, Hall EJ: Computed tomography: an increasing source of radiation exposure. N Engl J Med 2007;357:2277–2284.
  42. Doll R, Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191–1308.
  43. Berrington de Gonzalez A, Darby S: Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet 2004;363:345–351.
  44. Krewski D, Zielinski JM, Hazelton WD, Garner MJ, Moolgavkar SH: The use of biologically based cancer risk models in radiation epidemiology. Radiat Prot Dosimetry 2003;104:367–376.
  45. Cardis E, Vrijheid M, Blettner M, et al: The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res 2007;167:396–416.
  46. Vrijheid M, Cardis E, Blettner M, et al: The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results. Radiat Res 2007;167:361–379.
  47. Peloquin JM, Pardi DS, Sandborn WJ, Fletcher JG, McCollough CH, Schueler BA, Kofler JA, Enders FT, Achenbach SJ, Loftus EV Jr: Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:2015–2022.
  48. Newnham E, Hawkes E, Surender A, James SL, Gearry R, Gibson PR: Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy? Aliment Pharmacol Ther 2007;26:1019–1024.
  49. Desmond AN, O’Regan K, Curran C, McWilliams S, Fitzgerald T, Maher MM, Shanahan F: Crohn’s disease: factors associated with exposure to high levels of diagnostic radiation. Gut 2008;57:1524–1529.
  50. Palmer L, Porter C, Kappelman M: Diagnostic ionizing radiation exposure in a population-based cohort of children with inflammatory bowel disease. Inflamm Bowel Dis 2008;12(suppl 3):S4–S5.
  51. Herlinger H: Guide to imaging of the small bowel. Gastroenterol Clin North Am 1995;24:309–329.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50